S100 Control (CLIA)
Ref QC584
S100 Control (CLIA) (QC584) is a device classified as IVD General made by Getein Biotech, Inc, registered in EUDAMED on 5 Nov 2026 (Basic UDI-DI B-06954414755152), active as of 7 Nov 2026.
Active
CE IVDD
Valid until
No date given
FDA recalls
Not applicable
Documents
None, self-declared
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD | NumberB-06954414755152 | Date5 Nov 2026 | StatusActive |
Official records
- EUDAMED public site B-06954414755152
Certificates
No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/IVDD Active
Specification
- Model / reference
- QC584
- Primary DI / UDI-DI
- 06954414755152, 06954414748666, 06954414756319, 06954414741742
- Basic UDI-DI
- B-06954414755152, B-06954414748666, B-06954414756319, B-06954414741742
- EMDN code
- W0102152005 Tumour marker controls
- Device class
- Class IVD General
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Spain
Manufacturer details
- EUDAMED SRN
- CN-MF-000017986
- Authorised representative
- CMC Medical Devices & Drugs SL ES-AR-000000293
Similar devices in this category
Other devices filed under TUMOUR MARKER CONTROLS.
- Access Hybritech p2PSA (QC) A56934 by Beckman Coulter, Inc.
- Alinity 07P9001 by Abbott Ireland Diagnostics
- ProGRP Control 105-010160-00 by Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- ARCHITECT 3P36-10 03P3610 by Abbott Ireland Diagnostics
- μTASWako DCP Control L 995-61301 by FUJIFILM WAKO PURE CHEMICAL CORPORATION
- VALIDATE® TUMOR MARKERS Test Set 407sa by LGC Clinical Diagnostics, Inc.
- μTASWako AFP-L3 Control H 993-61101 by FUJIFILM WAKO PURE CHEMICAL CORPORATION
- CA50 Control EIM4298112 by Maccura Biotechnology Co., Ltd.
- Atellica IM cPSA QC 10995547 by Siemens Healthcare Diagnostics Inc.
- NSE Control EIM4296567 by Maccura Biotechnology Co., Ltd.